- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06913231
Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students
November 26, 2025 updated by: Rokaia Ali Zainelabedeen Mohamed Toson, Cairo University
Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students: A Randomized Controlled Trial
Obesity has become a significant public health concern globally, particularly among university students, where lifestyle changes contribute to increased body weight and fat accumulation.
The World Health Organization defines obesity as a condition characterized by excessive fat accumulation that presents a risk to health, with a body mass index (BMI) of 30 or higher being a common threshold for classification.
In Saudi Arabia, the prevalence of obesity among young adults is alarming, necessitating effective interventions to combat this issue.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sakaka
-
Jouf, Sakaka, Saudi Arabia
- College of Applied Medical Sciences, Jouf University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male and female University students with BMI ≥ 25, and their age between 18-25 years.
Exclusion Criteria:
- Musculoskeletal, neurological and cardiovacular conditionds,in addition to pregnancy and insrtion of pacemekers or other metal implants.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study group
The study group (no = 16) underwent whole-body vibration (WBV) training using the PowerPlate device.
Sessions will be conducted three times per week for 6 weeks.
|
Whole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA).
The vibration frequency was set between 30-40 Hz, with an amplitude of 2-4 mm.
|
|
Sham Comparator: Control group
The sham WBV group (no=16) will stand on the same device with the vibtation shut off.
Sessions will be conducted three times per week for 6 weeks.
|
A sham Whole body vibration will be used .
participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index
Time Frame: 6 weeks
|
BMI will be calculated as weight (kg) divided by height (m²).
|
6 weeks
|
|
Waist circumference
Time Frame: 6 weeks
|
WC will be measured at the midpoint between the lower rib and iliac crest using a non-stretchable measuring tape.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body fat percentage
Time Frame: 6 weeks
|
A smart scale will be used to measure body composition including the percentage of whole bofy fat.
|
6 weeks
|
|
Visceral mass
Time Frame: 6 weeks
|
Visceral fat will be assesed also using the same smart scale using the bioelectrical impedance analysis.
|
6 weeks
|
|
Lean body mass
Time Frame: 6 weeks
|
bioelectrical impedance analysis will be also used via a smart scale to measure the total lean body mass in (kg).
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 6, 2025
Primary Completion (Actual)
June 6, 2025
Study Completion (Actual)
August 18, 2025
Study Registration Dates
First Submitted
March 30, 2025
First Submitted That Met QC Criteria
April 4, 2025
First Posted (Actual)
April 6, 2025
Study Record Updates
Last Update Posted (Estimated)
December 3, 2025
Last Update Submitted That Met QC Criteria
November 26, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7586
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Whole body vibration device
-
Cairo UniversityRecruitingOverweight , ObesitySaudi Arabia
-
Koç UniversityCompletedPostpolio SyndromeTurkey
-
University of LiegeCompleted
-
University of Erlangen-Nürnberg Medical SchoolElsbeth-Bonhoff-Stiftung, BerlinTerminatedPostmenopausalGermany
-
Çağtay MadenCompletedWhole Body VibrationTurkey
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Gazi UniversityGulhane Training and Research HospitalCompletedArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
The Hong Kong Polytechnic UniversityCompleted
-
The Hong Kong Polytechnic UniversityUnknown